⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL1334491 | 0.97 | — | — | |
| SCHEMBL16826742 | 0.83 | — | — | |
| SCHEMBL16827017 | 0.83 | — | — | |
| SCHEMBL13286319 | 0.81 | — | — | |
| Hydrochloric Acid SCHEMBL21408438 | 0.79 | ODC1 (0.41) | — | |
| SCHEMBL20561085 | 0.79 | NFKB1 (0.39) | — | |
| SCHEMBL1717819 | 0.78 | — | — | |
| SCHEMBL16081665 | 0.78 | — | — | |
| SCHEMBL31051707 | 0.77 | DNM1 (0.42) | — | |
| SCHEMBL9240401 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 192 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117457970-B | Asymmetric heterogeneous boron center anion magnesium electrolyte salt, electrolyte, and preparation method and application thereof | 重庆大学 | 2024-07-16 | — | — | CN | claimed |
| CN-115692845-B | Halogen-free rechargeable magnesium battery electrolyte except fluorine, and preparation method and application thereof | 重庆大学 | 2024-02-02 | — | — | CN | claimed |
| CN-117457970-A | Asymmetric heterogeneous boron center anion magnesium electrolyte salt, electrolyte, and preparation method and application thereof | 重庆大学 | 2024-01-26 | — | — | CN | claimed |
| CN-115692845-A | Halogen-free rechargeable magnesium battery electrolyte and preparation method and application thereof | 重庆大学 | 2023-02-03 | — | — | CN | claimed |
| EP-2867224-B1 | PYRROLIDINE DERIVATIVES AND THEIR USE AS COMPLEMENT PATHWAY MODULATORS | NOVARTIS AG (CH) | 2017-07-26 | — | — | EP | claimed |
| US-9388199-B2 | Pyrrolidine derivatives and their use as complement pathway modulators | NOVARTIS AG (CH) | 2016-07-12 | — | — | US | claimed |
| US-20150166578-A1 | PYRROLIDINE DERIVATIVES AND THEIR USE AS COMPLEMENT PATHWAY MODULATORS | NOVARTIS AG (CH) | 2015-06-18 | — | — | US | claimed |
| US-20260116868-A1 | CBL-B INHIBITORS AND METHODS OF USE THEREOF | ARCUS BIOSCIENCES, INC. (US) | 2026-04-30 | — | — | US | disclosed |
| EP-4720055-A1 | CBL-B INHIBITORS AND METHODS OF USE THEREOF | Arcus Biosciences, Inc. (US) | 2026-04-08 | — | — | EP | disclosed |
| US-20260027090-A1 | Methods of Inhibiting Osteoclastogenesis and Osteoclast Activity | VTV THERAPEUTICS LLC (US) | 2026-01-29 | — | — | US | disclosed |
| US-12528781-B2 | Heterocyclic GLP-1 agonists | GASHERBRUM BIO, INC. (US) | 2026-01-20 | — | — | US | disclosed |
| EP-4656241-A2 | GONADOTROPIN-RELEASING HORMONE ANTAGONIST, AND PREPARATION METHOD THEREFOR AND USE THEREOF | Shandong Luye Pharmaceutical Co., Ltd. (CN) | 2025-12-03 | — | — | EP | disclosed |
| EP-4653436-A1 | HETEROCYCLIC COMPOUNDS, PREPARATION METHOD THEREFOR AND USE THEREOF | GUANGZHOU YUFAN NANTU BIOTECHNOLOGIES CO., LTD (CN) | 2025-11-26 | — | — | EP | disclosed |
| US-8759535-B2 | Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof | HIGH POINT PHARMACEUTICALS, LLC (US) | 2014-06-24 | — | — | US | disclosed |
| WO-2014086739-A1 | NOVEL BENZIMIDAZOLE DERIVATIVES AS EP4 ANTAGONISTS | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2014-06-12 | — | — | WO | disclosed |
| WO-2014064219-A1 | 1 H-INDOLE-3-CARBOXAMIDE DERIVATIVES AND USE THEREOF AS P2Y12 ANTAGONISTS | SANOFI (FR) | 2014-05-01 | — | — | WO | disclosed |
| EP-2725025-A1 | Derivatives of 1H-indole-3-carboxamide and their use as P2Y12 antagonists | SANOFI (FR) | 2014-04-30 | — | — | EP | disclosed |
| EP-2616448-A1 | SUBSTITUTED PHENYLACETATE AND PHENYLPROPANE AMIDES AND USE THEREOF | Bayer Intellectual Property GmbH (DE) | 2013-07-24 | — | — | EP | disclosed |
| EP-2536285-A1 | SUBSTITUTED FUSED IMIDAZOLE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE THEREOF | High Point Pharmaceuticals, LLC (US) | 2012-12-26 | — | — | EP | disclosed |
| WO-2012035075-A1 | SUBSTITUTED PHENYLACETATE AND PHENYLPROPANE AMIDES AND USE THEREOF | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2012-03-22 | — | — | WO | disclosed |